▶️ Finding your voice (among all the noise)
▶️ Expand your network
▶️ Promote your research
📆 Friday, May 30th
⏰ 3:00-3:45PM
📍Hall C, ASCO Trainee Lounge
@ASCOTECAG
▶️ Finding your voice (among all the noise)
▶️ Expand your network
▶️ Promote your research
📆 Friday, May 30th
⏰ 3:00-3:45PM
📍Hall C, ASCO Trainee Lounge
@ASCOTECAG
Here are #ASCO25 Top Lung Cancer Abstract Presentations to watch for -Part 1
Not a lot of new drugs but important updates on #perioperative and #targetedtherapy trials. Full abstracts available 5/22.
#lcsm
@hemoncfellows @hemoncmiami @sylvestercancer
Here are #ASCO25 Top Lung Cancer Abstract Presentations to watch for -Part 1
Not a lot of new drugs but important updates on #perioperative and #targetedtherapy trials. Full abstracts available 5/22.
#lcsm
@hemoncfellows @hemoncmiami @sylvestercancer
Updates on #perioperative and #targetedtherapy trials.
#CM77T #CM816, #NEOADAURA, #ALNEO, #SACHI, #KRYSTAL-2 #lcsm
@hemoncfellows @hemoncmiami @sylvestercancer
Updates on #perioperative and #targetedtherapy trials.
#CM77T #CM816, #NEOADAURA, #ALNEO, #SACHI, #KRYSTAL-2 #lcsm
@hemoncfellows @hemoncmiami @sylvestercancer
#drugshortages
#physicianadvocates @ascocancer @sylvestercancer
#drugshortages
#physicianadvocates @ascocancer @sylvestercancer
#ASCOAdvocacy
#ASCOAdvocacy
for naming me an Advocacy Champion at the #ASCOAdvocacySummit. I am proud to advocate on issues important to our patients like
#PriorAuth
#CancerResearch #NIHFunding
#DrugShortages
Looking forward to impactful conversations at Capitol Hill tomorrow!
@SylvesterCancer
for naming me an Advocacy Champion at the #ASCOAdvocacySummit. I am proud to advocate on issues important to our patients like
#PriorAuth
#CancerResearch #NIHFunding
#DrugShortages
Looking forward to impactful conversations at Capitol Hill tomorrow!
@SylvesterCancer
Florida delegation ready to speak to legislators about @ASCO bipartisan priorities:
✅NIH Cancer Research
✅Prior Authorization Bill
✅Cancer Drug Shortages
#physicianadvocates #beatthetable
Florida delegation ready to speak to legislators about @ASCO bipartisan priorities:
✅NIH Cancer Research
✅Prior Authorization Bill
✅Cancer Drug Shortages
#physicianadvocates #beatthetable
👉🏽see patient story in Spanish here: youtu.be/N7SZ2iNfP8g #lcsm
👉🏽see patient story in Spanish here: youtu.be/N7SZ2iNfP8g #lcsm
‼️Awaited OS data for #Amivantamab + lazertinib vs osimertinib in 1L EGFRm advanced #lungcancer presented at #ELCC25
🎯OS HR 0.75 (95%CI: 0.61-0.92)
🎉> 1 yr mOS advantage
🚫no crossover allowed, ⬆️intracranial activity
⬇️toxicity over time w prophylactic mgmt (skin)
#lcsm
‼️Awaited OS data for #Amivantamab + lazertinib vs osimertinib in 1L EGFRm advanced #lungcancer presented at #ELCC25
🎯OS HR 0.75 (95%CI: 0.61-0.92)
🎉> 1 yr mOS advantage
🚫no crossover allowed, ⬆️intracranial activity
⬇️toxicity over time w prophylactic mgmt (skin)
#lcsm
Good night from Times Square New York at #GDST25 Getting ready to debate the utility of CTLA4i drugs in #lungcancer #GreatDebatesSolidTumors @SylvesterCancer
Good night from Times Square New York at #GDST25 Getting ready to debate the utility of CTLA4i drugs in #lungcancer #GreatDebatesSolidTumors @SylvesterCancer
➡️ fertility preservation options for men/women/children
➡️ established and emerging methods discussed
➡️ fertility preservation options for men/women/children
➡️ established and emerging methods discussed
with @LuisRaezMD @mhshospital @MikeCusnir @MountSinaiMiami @BrunaPellini @MoffitNews
🗓️ Thu, March 13thm 5:0PM-8:00PM
📍 Trump International Resort, Sunny Isles FL
@sylvestercancer #lcsm
with @LuisRaezMD @mhshospital @MikeCusnir @MountSinaiMiami @BrunaPellini @MoffitNews
🗓️ Thu, March 13thm 5:0PM-8:00PM
📍 Trump International Resort, Sunny Isles FL
@sylvestercancer #lcsm
📆Saturday, March 8, 2025
⏰ 8AM
📍 Hollywood North Beach Park
👉🏽Support our team here: buff.ly/bj3gO3l
#lcsm
📆Saturday, March 8, 2025
⏰ 8AM
📍 Hollywood North Beach Park
👉🏽Support our team here: buff.ly/bj3gO3l
#lcsm
▶️ Discussion of 2nd line options
▶️ Update on T-Dxd for HER2 IHC3+ lungcancer
▶️ No consensus on use of TTF, Dato-DXd
👉🏽 ascopubs.org/doi/10.1200/...
▶️ Discussion of 2nd line options
▶️ Update on T-Dxd for HER2 IHC3+ lungcancer
▶️ No consensus on use of TTF, Dato-DXd
👉🏽 ascopubs.org/doi/10.1200/...
📅 Sept 6–9, 2025 | Barcelona. 🔹 Registration & Abstract Submission OPEN! Join top experts & rising stars to shape the future of lung cancer care. 🔗 Register/Submit: https://bit.ly/IASLCWCLC #WCLC25 #LungCancer #lcsm
📅 Sept 6–9, 2025 | Barcelona. 🔹 Registration & Abstract Submission OPEN! Join top experts & rising stars to shape the future of lung cancer care. 🔗 Register/Submit: https://bit.ly/IASLCWCLC #WCLC25 #LungCancer #lcsm
📅 Deadlines to nominate/accept:
👥 Colleague: 3/10/25
🙋 Self: 3/12/25
📅 Deadlines to nominate/accept:
👥 Colleague: 3/10/25
🙋 Self: 3/12/25
@JTOonline @IASLC @OncologyAdvance #LCSM
@JTOonline @IASLC @OncologyAdvance #LCSM